




Searching News Database: Talecris Biotherapeutics
HSMN NewsFeed - 8 Jan 2010
Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
HSMN NewsFeed - 2 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
HSMN NewsFeed - 5 Sep 2006
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
HSMN NewsFeed - 29 Aug 2006
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
HSMN NewsFeed - 24 Feb 2006
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
Additional items found! 4

Members Archive contains
4 additional stories matching:
Talecris Biotherapeutics
(Password required)
Talecris Biotherapeutics
(Password required)